Piper Report
Blog on Medicare, Medicaid, pharma, biotech, health reform, and more. Insights and resources on hot issues. Kip Piper, editor.
Kip Piper, MA, FACHE
Health care strategist, speaker, and writer. Expert on Medicare, Medicaid, and pharma, biotech, and device industries. President, Health Results Group LLC. Senior Counselor, Fleishman-Hillard. Senior Consultant, Sellers Dorsey. Visit KipPiper.com. Or email Kip here.
Cartoon
Medicare Resources
Medicare Advantage Rates
Special Needs Plans Data
Medicare Advantage Enrollment
Medicare Enrollment Data
Medicare Payment Advisory Commission
Centers for Medicare & Medicaid Services
Medicaid Resources
Federal Matching Rates (FMAP)
State Medicaid Expenditure Reports
State Medicaid Agencies
State Coverage Initiatives
Federal Medicaid Rules (CMS)
Federal Medicaid Statutes (Title 19)
State Health Facts
Sellers Dorsey
Center for Health Care Strategies
National Association of State Medicaid Directors
Pharma & Biotech Resources
FDA Advisory Committees on Drugs
FDA Advisory Committees on Biologics
Partnership for Prescription Assistance
PhRMA
Biotechnology Industry Organization
Pharmacy Quality Alliance
National Council for Prescription Drug Programs
FDA Approved Drugs
Clinical Trials Database
Medical Device Resources
FDA Advisory Committees on Devices
Advanced Medical Technology Association
FDA Approved Devices
FDA Medical Device Database
Health Reform Resources
Center for Studying Health System Change
Health Care Innovations Exchange
Alliance for Health Reform
Health I.T. Resources
National H.I.T. Resource Center
National Association of Health Data Organizations
H.I.T. Clearinghouse
HHS Health Information Technology Office
Quality & Safety Resources
State Quality Improvement Institute
Center for Health Transformation
Institute for Healthcare Improvement
The Leapfrog Group
National Guideline Clearinghouse
Comparative Effectiveness Reviews
National Quality Measures Clearinghouse
National Quality Forum
Ambulatory Quality Alliance
Hospital Quality Alliance
Consumer-Purchaser Disclosure Project
Legislative Resources
Senate Health, Education, Labor, and Pensions Committee
Senate Finance Committee
House Oversight Committee
House Ways & Means Committee
House Energy and Commerce Committee
National Conference of State Legislatures
Health Legislation by Topic
Find Congressional Bills
Government Accountability Office
Congressional Research Service
Congressional Budget Office
Regulatory Resources
Rules Under OMB Review
Federal Register
Office of Management and Budget
American Flag

April 2007
Building the Case for Drug Product Coverage and Reimbursement: Podcast
posted: April 16, 2007

Case%20for%20Product%20Reimbursement.jpgAs they move corporate resources from sales to R&D; and attempt to adapt to new business dynamics, pharma and biotech companies must become far smarter in building the case for coverage and reimbursement. Increasingly, drug makers are understanding the need to build the case early in drug discovery and development, demonstrate the value proposition, and effectively communicate - or even partner - with payors (health plans, drug plans, PBMs) and purchasers (Medicare, Medicaid, employers).


To learn more, please listen to Mark Senak's latest podcast. In it, I briefly explain the need to build value-driven, payor-friendly cases for drug coverage and reimbursement and to do so early.


Eye on FDA is Mark Senak's popular blog on drug industry regulation, the FDA, and strategic communications strategies. In addition to providing thoughtful analyses and useful resources in his blog, Mark also podcasts interviews with industry executives, FDA officials, and top thought leaders.

Related | Permalink
Consider This
In ancient China, physicians were paid only when their patients were kept well and often not paid if the patient got sick. If a patient died, a special lantern was hung outside the doctor's house. Upon each death, another lantern was added. This is the first known use of the two most powerful drivers for health care performance - incentives and transparency.
Our Staff
Kevin 'Kip' Piper
Kip Piper
Editor (on a real good day)

Watson the Dog
Watson Piper
Managing Editor
Profile of Kip Piper, MA, FACHE

Healthcare Consultant
President of Health Results Group LLC. Senior counselor with Fleishman-Hillard, the top public relations and communications consultancy. Senior consultant with Sellers Dorsey, influential Medicaid and health reform consultancy. Senior counselor, TogoRun, leading advisors in health care public affairs.

Expertise
Leading authority on Medicare, Medicaid, and health reform. Specialist in pharmaceutical, biotechnology, medical device, and health plan industry issues. Policy, finance, coverage, reimbursement, health and drug benefits, marketing, business development, innovation, and public affairs.

Strategic Advisor
Advised Fortune 100 companies, pharma and biotech firms, medical device firms, top federal officials, governors, members of Congress, foundations, and foreign leaders. Skilled, creative business and policy strategist and problem solver.

Speaker
Popular speaker at health industry conferences. Topics include Medicare, pharma business issues, Medicaid reform, coverage and reimbursement, and health innovation. Keynotes, seminars, and briefings.

Thought Leader
Testified before Congressional committees, negotiated major legislation, led groundbreaking programs, and designed and implemented numerous health innovations.

Blogger
Editor of the Piper Report, a leading health care blog with thousands of regular readers. Medicare, Medicaid, pharma, biotech, and more. News, advice, solutions, and resources.

Writer
Upcoming books include Medicare and Medicaid from A to Z and MediStrategy: Medicare and Medicaid Business Strategies.

Editor
Business and policy editor of American Health & Drug Benefits, peer reviewed journal for decision makers in health plans, drug plans, PBMs, CMS, states, and large employers, with circulation of 30,000.

Learn More
To learn more, please visit Kip at www.kippiper.com.
linked-in.gif
Syndicate Piper Report
AtomEnabled RSS feed